RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, announced today the addition of Edward L. Erickson to Metabolon’s board of directors. Erickson’s addition to the board adds valuable experience in diagnostic development and commercialization.
